<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-129010</identifier>
<setSpec>0212-6982</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">False negative of the scintigraphy with 99mTc-sestamibi in parathyroid carcinoma with associated brown tumors. Contributions of the 18F-FDG-PET/CT</dc:title>
<dc:description xml:lang="en">Parathyroid carcinoma (PTC) is a rare malignant disease that is usually hyperfunctioning, which produces an excess of parathyroid hormone. Hyperparathyroidism causes bone metabolism disorders, as osteopenia and sometimes brown tumors. Brown tumors are benign but locally aggressive bone lesions, whose differential diagnosis with metastases or other primary malignancies may be complicated. 99mTc-Sestamibi scan is the usual procedure for the detection of parathyroid pathology, with a sensitivity of 85&#150;100% and specificity close to 100% in parathyroid adenomas, it having similar percentages in the detection of PTC. We present the case of a patient diagnosed of a malignant hyperparathyroidism associated with bone lesions in which the 99mTc-Sestamibi scan showed a false negative result in the detection of parathyroid condition. However, 18F-FDG-PET/CT detected the PTC and helped in the differential diagnosis of associated bone lesions, which were finally confirmed as brown tumors(AU)</dc:description>
<dc:creator>Santiago Chinchilla, A</dc:creator>
<dc:creator>Llamas Elvira, J. M</dc:creator>
<dc:creator>Ramos Font, C</dc:creator>
<dc:creator>Palacios Gerona, H</dc:creator>
<dc:creator>Moreno Caballero, M</dc:creator>
<dc:creator>Muros de Fuentes, M. A</dc:creator>
<dc:creator>Navarro-Pelayo Láinez, M</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">El carcinoma paratiroideo (CPT) es un tumor poco frecuente que suele ser hiperfuncionante, produciendo un exceso de hormona paratiroidea. El hiperparatiroidismo produce trastornos del metabolismo óseo, como osteopenia y en ocasiones tumores pardos. Los tumores pardos son lesiones óseas benignas, pero localmente destructivas, cuyo diagnóstico diferencial con metástasis u otros tipos de tumores primarios puede ser complicado. La técnica habitual para la detección de patología paratiroidea es la gammagrafía con 99mTc-sestamibi, con una sensibilidad del 85&#150;100% y una especificidad cercana al 100% en adenomas paratiroideos, presentando cifras muy similares en la detección del CPT. Presentamos el caso de un paciente diagnosticado de hiperparatiroidismo de origen tumoral con lesiones óseas asociadas en el que la gammagrafía con 99mTc-sestamibi presentó un falso negativo en la detección de patología paratiroidea. Sin embargo, la PET/TAC-18F-FDG detectó el CPT y ayudó en el diagnóstico diferencial de las lesiones óseas asociadas, que fueron finalmente tumores pardos(AU)</dc:description>
<dc:source>Rev Esp Med Nucl;30(3): 174-179, mayo-jun. 2011.</dc:source>
<dc:identifier>ibc-129010</dc:identifier>
<dc:title xml:lang="es">Falso negativo de la gammagrafía con 99mTc-sestamibi en un carcinoma paratiroideo con tumores pardos asociados. Aportaciones de la PET/TAC-18F-FDG</dc:title>
<dc:subject>^d24339^s22045</dc:subject>
<dc:subject>^d10470^s22012</dc:subject>
<dc:subject>^d5289</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d29310</dc:subject>
<dc:subject>^d30483^s29165</dc:subject>
<dc:subject>^d30483^s22022</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d10470^s22016</dc:subject>
<dc:subject>^d7140^s22012</dc:subject>
<dc:subject>^d30483^s22079</dc:subject>
<dc:subject>^d2320^s29166</dc:subject>
<dc:subject>^d2320^s22016</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d1876^s22012</dc:subject>
<dc:subject>^d38793^s22045</dc:subject>
<dc:subject>^d30483</dc:subject>
<dc:type>article</dc:type>
<dc:date>201106</dc:date>
</metadata>
</record>
</ibecs-document>
